NCT01685294 Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression Status COMPLETED Phase PHASE3
NCT01684163 Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants Status COMPLETED Phase PHASE2
NCT01682785 Incidence of Metabolic Syndrome and Thyroid Dysfunction in Patients With Major Depressive Disorder Status UNKNOWN Phase N/A
NCT01671124 The Study of Antidepressant Properties and Safety of Fer-01(Soline®) on the Patients With Depression Status UNKNOWN Phase N/A
NCT01670279 Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder Status COMPLETED Phase PHASE1
NCT01667926 Ketamine Versus Placebo for Treatment Resistant Major Depressive Disorder Status COMPLETED Phase NA
NCT01655706 Canadian Biomarker Integration Network for Depression Study Status COMPLETED Phase PHASE3
NCT01650740 Study of Placebo Without Deception Versus Standard Antidepressant for Major Depressive Disorder Status TERMINATED Phase NA
NCT01640483 Differential Efficacy of Supportive and Interpretative Psychodynamic Techniques for Dependent and Self-critical Depressive Patients Status COMPLETED Phase NA
NCT01640080 A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression Status COMPLETED Phase PHASE2
NCT01633437 Oral Tyramine Pressor Response Study of CX157 Tablets in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT01627782 A Study of Ketamine in Patients With Treatment-resistant Depression Status COMPLETED Phase PHASE2
NCT01625845 Anti-INFLammatory to Address Mood and Endothelial Dysfunction (INFLAMED) Status COMPLETED Phase PHASE2
NCT01613820 Ketamine and Scopolamine Infusions for Treatment-resistant Major Depressive Disorder Status WITHDRAWN Phase NA
NCT01608399 Clinical Trial of the Effectiveness of Metacognitive Therapy in the Treatment of Patients With Major Depressive Disorder Status COMPLETED Phase NA
NCT01606384 Evaluation of the Potential Effects of SSR149415 on the Hypothalamic-pituitary-adrenal Axis in Outpatients With Major Depressive Disorder Status COMPLETED Phase PHASE2
NCT01601210 Dose-Ranging Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder Status COMPLETED Phase EARLY_PHASE1
NCT01601002 LEPR Polymorphism Weight Gain by Mirtazapine in Late Life Depression Status COMPLETED Phase PHASE4